Insmed To Present at Two September Conferences

Rhea-AI Summary

Insmed Incorporated announced participation in two upcoming investor events, aiming to engage with stakeholders. The events include the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, 2022, at 9:55 a.m. ET, and the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 5:00 p.m. ET. Both fireside chats will be webcasted and available for 30 days post-event. Insmed focuses on developing therapies for serious and rare diseases and is headquartered in Bridgewater, New Jersey.

BRIDGEWATER, N.J., Sep. 6, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor events:

• The Morgan Stanley 20^th Annual Global Healthcare Conference in New York, NY on September 12, 2022 at 9:55 a.m. ET in a fireside chat
• The H.C. Wainwright 24^th Annual Global Investment Conference in New York, NY on September 13, 2022 at 5:00 p.m. ET in a fireside chat

Each fireside chat will be webcast and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the respective presentation dates.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-two-september-conferences-301617976.html

SOURCE Insmed Incorporated

FAQ

When will Insmed present at the Morgan Stanley conference?

Insmed will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 9:55 a.m. ET.

What is the date of Insmed's presentation at the H.C. Wainwright conference?

Insmed will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 5:00 p.m. ET.

How can I access Insmed's investor presentations?

Insmed's presentations will be webcast and can be accessed through the investor relations section of their website.

What is the focus of Insmed's biopharmaceutical development?

Insmed focuses on transforming the lives of patients with serious and rare diseases through innovative therapies.

Where is Insmed Incorporated headquartered?

Insmed is headquartered in Bridgewater, New Jersey.